See below for the full list of every contraceptives and women's health stock in Carbon Collective's Climate Index.

Safeguarding women's right to family planning can reduce overall carbon footprint.

 

Around 225 million women in lower-income countries say they want to be able to choose whether and when to become pregnant but don't have access to contraception. The lack of access to contraceptives leads to some 75 million unintended pregnancies each year. 

Many women in high-income countries don't have access to contraceptives, either. For example, nearly half of pregnancies in the United States are unintended. Securing the right to voluntary, high-quality family planning services and contraception around the world would have significant positive impacts on the health, welfare, and life expectancy of both women and their children. 

It would also massively benefit the environment. Every person on Earth consumes resources and causes emissions throughout their lifetime. If contraceptives are widely provided and women's health are secured, the reduced population size could avoid up to 85.42 gigatons of greenhouse gases from 2020 and 2050.

 

It's not government control over reproduction. It's women's right to choose.

The topic of limiting population growth is not often discussed because it invokes fears about coercive or cruel efforts by centralized governments to force the birth rate down (or up). 

But this Drawdown solution is the polar opposite. It's about giving women the right to choose whether or not to have children and to plan her future. The right to family planning through easy access to contraception can meet women's needs, empowerment, equality, and well-being. Benefits to the environment and climate are welcome side effects.

Companies can help fill this gap.

Contraceptives and women's health stocks are included in the Climate Index if at least 50% of a company's revenue comes from contraceptive products. And as always, we exclude penny stocks whose share prices were less than $0.50 in our last update.

If you are a Carbon Collective member, you own all of these companies through the Climate Index.

Clean Energy Stocks in the Climate Index

Filters:
Index Status:
% ALLOCATED icon Company Type icon Company icon Category icon DESCRIPTION 
-
Contraceptives
Abbvie
Failed Contraceptive Filter
Abbvie makes less than 50% of its revenue from contraceptives, thus failing the contraceptives filter.
0.02%
Pure Play
Agile makes 100% of its revenue from selling a prescription combination hormonal contraceptive patch.
-
Contraceptives
Church & Dwight
Failed Contraceptive Filter
Church & Dwight owns Trojan condoms, but makes less than 50% of its revenue from them, thus failing to pass the contraception filter.
0.02%
Pure Play
Evofem makes 100% of it's revenue from a contraceptive gel. They are also working on a vaginal gel that reduces certain infections.
-
Contraceptives
Merck & Co
Failed Contraceptive Filter
Merck sells prescription medicines, vaccines, animal health products, and more and makes less than 50% of its revenue from contraceptives
-
Contraceptives
ObsEva SA
No Drawdown Solution
ObsEva makes health and pregnacy-related products, but not contraceptives, meaning it does make a Drawdown solution
-
Contraceptives
Pfizer
Lacks Sufficient Information
It is unclear what the revenue breakdown of Pfizer's contraceptive and non-contraceptive products is.
-
Contraceptives
Teva Pharmaceutical Industries
Lacks Sufficient Information
It is unclear what the revenue breakdown of Teva's contraceptive and non-contraceptive products is.
-
Contraceptives
The Cooper Companies
Failed Contraceptive Filter
Cooper sells healthcare products like contact lenses, fertility products, and contraceptives, but makes less than 50% of its revenue from contraceptives
-
Contraceptives
TherapeuticsmMD
Lacks Sufficient Information
It is unclear what the revenue breakdown of TherapeuticsmMD's contraceptive and non-contraceptive products is.
0.03%
Passed Contraceptive Filter
Veru makes more than 50% of its revenue from selling contraceptives and also develops medicines related to prostate and breast cancer.
Abbvie makes less than 50% of its revenue from contraceptives, thus failing the contraceptives filter.
Failed Contraceptive Filter
Agile makes 100% of its revenue from selling a prescription combination hormonal contraceptive patch.
Pure Play
Church & Dwight owns Trojan condoms, but makes less than 50% of its revenue from them, thus failing to pass the contraception filter.
Failed Contraceptive Filter
Evofem makes 100% of it's revenue from a contraceptive gel. They are also working on a vaginal gel that reduces certain infections.
Pure Play
Merck sells prescription medicines, vaccines, animal health products, and more and makes less than 50% of its revenue from contraceptives
Failed Contraceptive Filter
ObsEva makes health and pregnacy-related products, but not contraceptives, meaning it does make a Drawdown solution
No Drawdown Solution
It is unclear what the revenue breakdown of Pfizer's contraceptive and non-contraceptive products is.
Lacks Sufficient Information
It is unclear what the revenue breakdown of Teva's contraceptive and non-contraceptive products is.
Lacks Sufficient Information
Cooper sells healthcare products like contact lenses, fertility products, and contraceptives, but makes less than 50% of its revenue from contraceptives
Failed Contraceptive Filter
It is unclear what the revenue breakdown of TherapeuticsmMD's contraceptive and non-contraceptive products is.
Lacks Sufficient Information
Veru makes more than 50% of its revenue from selling contraceptives and also develops medicines related to prostate and breast cancer.
Passed Contraceptive Filter
Failed Contraceptive Filter
Abbvie makes less than 50% of its revenue from contraceptives, thus failing the contraceptives filter.
Pure Play
Agile makes 100% of its revenue from selling a prescription combination hormonal contraceptive patch.
Failed Contraceptive Filter
Church & Dwight owns Trojan condoms, but makes less than 50% of its revenue from them, thus failing to pass the contraception filter.
Pure Play
Evofem makes 100% of it's revenue from a contraceptive gel. They are also working on a vaginal gel that reduces certain infections.
Failed Contraceptive Filter
Merck sells prescription medicines, vaccines, animal health products, and more and makes less than 50% of its revenue from contraceptives
No Drawdown Solution
ObsEva makes health and pregnacy-related products, but not contraceptives, meaning it does make a Drawdown solution
Lacks Sufficient Information
It is unclear what the revenue breakdown of Pfizer's contraceptive and non-contraceptive products is.
Lacks Sufficient Information
It is unclear what the revenue breakdown of Teva's contraceptive and non-contraceptive products is.
Failed Contraceptive Filter
Cooper sells healthcare products like contact lenses, fertility products, and contraceptives, but makes less than 50% of its revenue from contraceptives
Lacks Sufficient Information
It is unclear what the revenue breakdown of TherapeuticsmMD's contraceptive and non-contraceptive products is.
Passed Contraceptive Filter
Veru makes more than 50% of its revenue from selling contraceptives and also develops medicines related to prostate and breast cancer.
Attend Our Next Webinar

Attend Our Next Webinar

Join our next Sustainable Investing 101 webinar, get our favorite DIY options, and walk through how we build our portfolios.

Register
Get Our Newsletter

Get Our Newsletter

Go a level deeper with us and investigate the potential impacts of climate change on investments like your retirement account.

Join Newsletter
Talk To A Human

Talk To A Human

Joining a new investment service can be intimidating. We’re here for you. Click below to email us a question or book a quick call.

Ask a Question